ABSTRACT Radioactive triiodothyronine reaching the rat brain after intravenous administration is rapidly and selectively taken up in the nerve ending fraction. A concentration gradient of radioactivity from brain cytosol to synaptosomes is observed at 5 min, increases linearly over the first hour, and is maintained for at least 10 hr. Radioactivity in the synaptosomes is due to triiodothyronine (90%) plus a single unidentified metabolite (10%). Approximately 85% of the synaptosomal radioactivity is released by osmotic disruption of the particles. The process of selective uptake, concentration, and retention of triiodothyronine in nerve terminals of the rat brain may be related to the sympathomimetic and behavior-altering effects of the thyroid hormones.
gle unidentified metabolite (10%). Approximately 85% of the synaptosomal radioactivity is released by osmotic disruption of the particles. The process of selective uptake, concentration, and retention of triiodothyronine in nerve terminals of the rat brain may be related to the sympathomimetic and behavior-altering effects of the thyroid hormones.
Thyroid hormones exert marked central stimulating and peripheral sympathomimetic effects, which are not explained by increased catecholamine production or enhanced adrenergic receptor sensitivity. On the contrary, circulating levels of catecholamines (1, 2) , turnover rates of noradrenaline in a number of tissues (3) (4) (5) , and sensitivity of at least some adrenergic receptors (6) (7) (8) are reported to be inversely correlated with the thyroid state. To explain their sympathomimetic actions, we have proposed that iodothyronines, like tyrosine and other tyrosine analogues, may be transformed to adrenergic neurotransmitters (9) .
The metabolic pathway leading from precursor amino acid to cific activity approximately 500 jiCi/jig in 50% (vol/vol) propylene glycol] or 50% propylene glycol was administered as a single dose intravenously and animals were decapitated 5, 20, 60, 180, and 600 min later. Blood was collected from the decapitation site and the serum was separated and analyzed for radioactivity and radioactive iodocompounds. Subcellular fractions of whole brain minus cerebellum were prepared according to the method of Whittaker et al. (10) . Briefly, following 1000 X g centrifugation of the brain homogenate for 10 min, nuclei and cellular debris were discarded, and the supernatant phase (Sl fraction) was layered on a discontinuous sucrose density gradient consisting of 1.2, 0.8, and 0.32 M sucrose, and centrifuged in a swinging bucket rotor at 50,000 X g for 1 hr. Individual gradient fractions including myelin, synaptosomes, and mitochondria were separated (see diagram, Table 1A ) and diluted with 10-18 volumes of isotonic Krebs buffer (11) , and pellets were separated by centrifugation at 20,000 X g for 20 min. To determine the extent of translocation of labeled T3 during the fractionation procedure, brains of animals which received intravenous propylene glycol without isotope were homogenized at 40 in sucrose containing 0.05 jgCi of [125I]T3. Approximately 75% of added ['25I]T3 was recovered in the cytosol (plus microsomes); the remainder was distributed among the various subcellular organelles as shown in Table  1B . All brain fractions labeled in vivo were corrected for in vitro uptake at 40. Radioactivity in individual subcellular fractions and in serum was studied by means of paper chromatography in three solvent systems: butanol:ethanol:0.5 M ammonia, 5:1:2; butanol:acetic acid:water, 4:1:1; and tertiary amyl alcohol:2 M ammonia:hexane, 5:6:1. Added carrier compounds were identified by means of ultraviolet light at 259 nm. After development, the radioactivity in each 1 cm segment of the chromatogram was counted for at least 10 min.
RESULTS
Following intravenous administration of [125IIT3 to rats, levels of radioactivity in the serum decreased over the 10 hr period, whereas, the concentration in the brain increased, reaching a plateau after the first hour (Fig. 1) . Medical Sciences: Dratman et al. into all subcellular particles (Table 1C and Fig. 2 ). However, within 5 min and throughout the first hour after [125I]Ts, radioactivity associated with the nerve endings was more than 2-fold greater than that exhibited by any other particulate subcellular component, and was still more than 50% greater at the end of the 3 hr period (Fig. 2) . Concentration of radioactivity in synaptosomes was calculated (11) and compared with concentration in the cytosol (see legend , Fig. 3) ; a ratio of synaptosomal to cytosol radioactivity greater than one was observed at 5 min; the ratio increased linearly over the first hour, and was maintained for at least 10 hr (Fig. 3) have increased further the cytosol to synaptosome concentration gradient.
To verify that the organelle identified as synaptosomes did, in fact, exhibit functional properties of nerve ending preparations, brain fractions from untreated animals were incubated in the presence of 0.4 ,uM [3H]norepinephrine. The synaptosomal component behaved as a nerve ending preparation, exhibiting a highly temperature-iependent uptake of norepinephrine (40-fold increase in uptake at 370).
To determine the identity of the radioactive compounds in individual subcellular components, suspensions of myelin, mitochondria, microsomes, and synaptosomes were applied to the origin of paper strips and the chromatograms were cpm in synaptosomes/mg brain . cpm in cytosol/mg brain 0J84 0.8 where brain density = 0.8 ml/g and synaptosomal density = 0.184 ml/g, derived from data in Fig. 4 of ref. 11. The concentration gradient relationship to time is described by means of a least squares straight line, the slope of which is + 0.0116 concentration gradient units/min (r = 0.93). The relationship is not linear after the first hour; differences between 1, 3, and 10 hr ratios are not significant. * = ratio in individual animals; = mean value at each time iii terval.
amounting to approximately 10%, as compared with approximately 90% Ts.
Synaptosomal membranes rupture when subjected to hypotonic conditions, resulting in release of contained precursor amino acids and neurotransmitter vesicles (12) . To the subcellular organelles, but is selectively taken up into the nerve ending (synaptosomal) fraction. Particle-bound radioactivity is virtually all accounted for by T3, except for an additional unidentified metabolite in the synaptosomal fraction. A concentration gradient of radioactivity from cytosol to synaptosomes is evident at 5 min, increases linearly over the first hour, and is maintained for at least 10 hr after administration of labeled hormone. More than 80% of the radioactivity in the synaptosomes is released by osmotic disruption of the particles. These observations provide evidence that T3 is taken up, concentrated, and retained within nerve endings. The presence of a metabolite of T3 detected only in the synaptosomes suggests that the hormone may be transformed within nerve terminals. Although evidence derived from experiments with salivary gland suggests a role for T3 in peripheral adrenergic nerves, there is no information available from the present experiments regarding the nature of the nerve endings which concentrate the hormone in brain.
The aromatic amino acids, tyrosine and phenylalanine, are actively taken up into nerve terminals (13) and form a variety of adrenergic neurotransmitters including norepinephrine, dopamine, epinephrine, and also octopamine, phenylethylamine, and phenylethanolamine (14) . Tyrosine analogues (e.g., a-methyl-m-tyrosine) are also concentrated in nerve endings, where they are converted to false adrenergic neurotransmitters (15) . The 
